Opzelura is a drug that is used for the treatment of atopic dermatitis on a short-term and non-continuous basis in non-immunocompromised teenage patients 12 years of age and older whose condition cannot be managed well enough with prescription medicines. People will occasionally dispute the effectiveness of the medication, and many are curious about how exactly Opzelura is doing its job.
We have crafted a short guide on all that Opzelura asserts to be, including the product’s potential adverse effects and specifics on its cost. Continue reading down below.
What is the mechanism of action behind Opzelura?
For the treatment of atopic dermatitis (eczema) in non-immunocompromised teenage patients 12 years of age and older, the medication is known as a Janus kinase inhibitor. The treatment is intended to be used on a short-term basis and not continuously. Ruxolitinib, which is the active component of Opzelura, inhibits JAK1 and JAK2 enzymes. These enzymes are responsible for controlling the signaling of cytokines and development factors, both of which play a significant role in hematopoiesis and the operation of the immune system.
Ruxolitinib cream, with a concentration of 1.5%, is sold under the brand name Opzelura. Keep in mind that it is essential to discuss with a professional any concerns about your health that you might have. You’ll receive the very finest care and assistance if you proceed in this manner.
Does Opzelura cause any adverse reactions?
In clinical studies, the following were the adverse reactions to Opzelura that occurred most frequently:
- Infection of the ear
- Eosinophil count increased
How much does it cost to buy Opzelura?
The topical cream form of Opzelura with a concentration of 1.5% normally costs $2,100 for a supply of 60 grams. There are, without a doubt, a lot of different discounts that may be obtained, but this is mostly determined by the store in which the drug is purchased. Additionally, the copay for Opzelura will be different for each individual based on the provisions of their particular healthcare plan.